Innovative MedTech Inc.
IMTH · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.02 | -0.01 | 0.04 | 0.11 |
| FCF Yield | 115.87% | -2.18% | -1.56% | -1.09% |
| EV / EBITDA | -1.21 | -1.67 | -4.05 | -3.37 |
| Quality | ||||
| ROIC | 675.78% | 238.90% | -152.86% | -756.12% |
| Gross Margin | 0.00% | 96.38% | 96.70% | 94.61% |
| Cash Conversion Ratio | 2.43 | 0.02 | 0.05 | 0.03 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | 12.03% | 70.32% | – |
| Free Cash Flow Growth | 1,417.21% | -28.77% | 71.15% | -2,339.29% |
| Safety | ||||
| Net Debt / EBITDA | -0.23 | -0.27 | -0.60 | -0.11 |
| Interest Coverage | 50.25 | -21.47 | -16.34 | -95.36 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | -2.57 |
| Cash Conversion Cycle | 0.00 | -7,249.82 | -6,943.76 | -7,987.87 |